BioCentury
ARTICLE | Distillery Therapeutics

Blocking NLRP3 deubiquitination for inflammasome-associated disease

April 30, 2021 7:27 PM UTC

DISEASE CATEGORY: Autoimmune; hepatic; infectious; inflammation

INDICATION: Multiple sclerosis (MS); liver disease; sepsis; inflammation...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article